- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07813078
Anti-Gravity Treadmill Gait Training for Knee Osteoarthritis
4 septembre 2026 mis à jour par: Piotr Pastyrzak, University of Rzeszow
Evaluation of the Effectiveness of Traditional Physiotherapy Supported by Gait Re-education Using the R-Force Anti-Gravity Treadmill in Patients With Knee Osteoarthritis - Randomized Clinical Trial
Purpose: The aim of the study will be to evaluate the effectiveness of traditional physiotherapy supported by gait re-education using the R-Force bodyweight-supported treadmill in improving gait parameters, range of motion, knee joint function, quality of life, and body composition in patients with knee osteoarthritis.
The study will be conducted in the form of a prospective, randomized clinical trial with participants divided into two therapeutic groups: a control group and an experimental group.
The therapeutic program will last 4 weeks and will be implemented 3 times a week.
Changes in gait parameters, range of motion, knee joint function, quality of life, and body composition will be evaluated.Material:
The study will include patients ≥ 40 years of age with knee osteoarthritis (Kellgren-Lawrence grade 2 or 3), confirmed radiologically, reporting pain lasting ≥ 3 months.
Participants (n = 80) will be randomly assigned to the control group (conventional physiotherapy) or the experimental group (conventional physiotherapy + training on the R-Force treadmill).Methods: Participants will be assessed at three time points: before the intervention (baseline), after completing the 4-week therapeutic program (postintervention), and after 8 weeks (follow-up).
The methods used will include: analysis of gait parameters on the R-Force treadmill, 6-Minute Walk Test (6MWT), Timed Up and Go (TUG) test, measurements of knee joint range of motion using a goniometer, thigh and lower leg circumference measurements, body composition analysis using the BIA method, subjective pain assessment using the Visual Analog Scale (VAS) and Laitinen scale, pressure pain threshold assessment using a digital algometer, functional assessment using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaires, quality of life assessment (WHOQOL-BREF), Hospital Anxiety and Depression Scale (HADS), as well as assessment of periarticular structures using ultrasound.
Aperçu de l'étude
Statut
Recrutement
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Estimé)
80
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: Piotr Pastyrzak, MSc
- Numéro de téléphone: 531-078-080
- E-mail: piotr.pastyrzak@gmail.com,
Lieux d'étude
-
-
Podkarpackie Voivodeship
-
Sanok, Podkarpackie Voivodeship, Pologne, 35-800
- Recrutement
- Centrum Rehabilitacji niemowląt, dzieci i dorosłych SensoReh Karolina Banaś - Pastyrzak,
-
Contact:
- Piotr Pastyrzak, MSc
- Numéro de téléphone: 531-078-080
- E-mail: piotr.pastyrzak@gmail.com
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- Radiologically confirmed knee osteoarthritis (grade 2 or 3 according to the Kellgren-Lawrence classification).
- General health and functional status allowing participation in the physical therapy program (based on clinical assessment).
- Knee joint pain persisting for at least 3 months, with an intensity of >= 4 on the Visual Analog Scale (VAS).
- Age between 40 and 70 years.
- Ability to ambulate independently without any orthopedic assistive devices.
- Voluntary written informed consent to participate in the study.
- No medical contraindications to physical exercise.
Exclusion Criteria:
- Knee osteoarthritis grade 4 according to the Kellgren-Lawrence classification or lack of radiological changes (grade 0-1).
- History of total or partial knee arthroplasty (joint replacement).
- Contraindications to body composition analysis (e.g., implanted pacemaker, electronic implants, epilepsy).
- Knee joint instability (e.g., ligamentous injury).
- Acute joint inflammation.
- Neuropathies, myopathies, or other neurological conditions affecting gait.
- Active neoplastic diseases (cancer) or advanced cardiovascular diseases.
- Participation in other clinical trials within the last 6 months.
- Participation in another physical therapy or rehabilitation program within the last 6 months.
- Planned intra-articular injections or injections received in the affected knee joint within the last 3 months.
- Regular use of analgesic or anti-inflammatory drugs (NSAIDs, corticosteroids) at doses that could affect the assessment of pain and function.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Experimental Group
Patients in this group will receive a comprehensive 4-week therapeutic program, 3 times a week.
The intervention combines conventional physiotherapy with gait re-education and training on the R-Force bodyweight- supported anti-gravity treadmill.
Each therapy session will last approximately 90 minutes.
|
A standard program consisting of targeted physical exercises, range of motion improvements, and strength conditioning for patients with knee osteoarthritis.
Traditional physiotherapy will include isometric exercises, strengthening, stretching, balance exercises (with elements of proprioception training), active non-weight-bearing exercises, functional exercises, gait exercises, as well as breathing and relaxation exercises.
Gait re-education and body-weight-supported treadmill training using the R-Force anti-gravity treadmill to reduce joint loading during exercise.
|
|
Comparateur actif: Control Group
Patients in this group will undergo a standard 4- week conventional physiotherapy program, 3 times a week.
Each therapy session will last approximately 90 minutes.
|
A standard program consisting of targeted physical exercises, range of motion improvements, and strength conditioning for patients with knee osteoarthritis.
Traditional physiotherapy will include isometric exercises, strengthening, stretching, balance exercises (with elements of proprioception training), active non-weight-bearing exercises, functional exercises, gait exercises, as well as breathing and relaxation exercises.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Délai: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in knee joint function and symptoms using the KOOS questionnaire.
The questionnaire assesses 5 subscales: Pain, Symptoms, Activities of Daily Living, Sport and Recreation Function, and Knee-related Quality of Life.
Scores range from 0 to 100, where 100 indicates no symptoms and 0 indicates extreme symptoms.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Gait Parameters - Stride Length
Délai: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in mean stride length (measured in centimeters) during treadmill walking, evaluated using the built-in spatio-temporal analysis system of the R-Force treadmill.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Subjective Pain Assessment using Visual Analog Scale (VAS)
Délai: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in self-reported knee pain intensity during movement using a 100 mm Visual Analog Scale, where 0 mm represents "no pain" and 100 mm represents "worst imaginable pain"
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Functional Walking Capacity via 6-Minute Walk Test (6MWT)
Délai: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in the maximum distance (measured in meters) that a participant can walk quickly on a flat, hard surface in a period of 6 minutes.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Mobility and Balance via Timed Up and Go (TUG) Test
Délai: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in the time (measured in seconds) taken by a participant to rise from a chair, walk 3 meters, turn around, walk back to the chair, and sit down.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Knee Joint Range of Motion (ROM)
Délai: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in active and passive knee joint flexion and extension angles, measured in degrees using a standard universal goniometer
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Pressure Pain Threshold (PPT)
Délai: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in pressure pain threshold at standardized periarticular sites around the knee, measured in kilograms per square centimeter (kg/cm2) using a digital pressure algometer.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Ultrasound Assessment of Periarticular Structures
Délai: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in structural features of periarticular tissues (such as joint effusion volume, synovial thickness, or tendon presentation) evaluated qualitatively and quantitatively via knee ultrasonography
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
5 janvier 2026
Achèvement primaire (Estimé)
31 décembre 2026
Achèvement de l'étude (Estimé)
30 juin 2027
Dates d'inscription aux études
Première soumission
4 septembre 2026
Première soumission répondant aux critères de contrôle qualité
4 septembre 2026
Première publication (Réel)
10 septembre 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
10 septembre 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
4 septembre 2026
Dernière vérification
1 mai 2026
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- Resolution No. 4/12/2025/W
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Description du régime IPD
Individual participant data will not be made publicly available due to institutional data protection regulations, patient privacy restrictions, and the scope of the doctoral research project.
Aggregate data and study findings will be disseminated exclusively through peer-reviewed scientific publications and conference presentations
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .